Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Randolph

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Nature Biotechnology|October 5, 2021
Engineered pegRNAs improve prime editing efficiencyJames W Nelson, Peyton B Randolph, Simon P Shen, et al.
Nature|October 22, 2019
Search-and-replace genome editing without double-strand breaks or donor DNAAndrew V Anzalone, Peyton B Randolph, Jessie R Davis, et al.
Nature Biotechnology|December 9, 2021
Author Correction: Engineered pegRNAs improve prime editing efficiencyJames W Nelson, Peyton B Randolph, Simon P Shen, et al.
Journal of Virology|May 14, 2004
Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitroMatthew B Elliott, Karin S Pryharski, Qingzhong Yu, et al.
The Journal of Infectious Diseases|March 5, 2005
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infantsRuth A Karron, Peter F Wright, Robert B Belshe, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 1998
Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutantR A Karron, D A Buonagurio, A F Georgiu, et al.
Vaccine|December 1, 1996
Identification of mutations contributing to the reduced virulence of a modified strain of respiratory syncytial virusK P Tolley, A C Marriott, A Simpson, et al.
Cell|January 12, 2022
Engineered virus-like particles for efficient in vivo delivery of therapeutic proteinsSamagya Banskota, Aditya Raguram, Susie Suh, et al.
Journal of Virology|July 29, 2004
Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) proteinMatthew B Elliott, Karin S Pryharski, Qingzhong Yu, et al.
Nature Biotechnology|May 4, 2023
Efficient prime editing in mouse brain, liver and heart with dual AAVsJessie R Davis, Samagya Banskota, Jonathan M Levy, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Nature Biotechnology|October 5, 2021
Engineered pegRNAs improve prime editing efficiencyJames W Nelson, Peyton B Randolph, Simon P Shen, et al.
Nature|October 22, 2019
Search-and-replace genome editing without double-strand breaks or donor DNAAndrew V Anzalone, Peyton B Randolph, Jessie R Davis, et al.
Nature Biotechnology|December 9, 2021
Author Correction: Engineered pegRNAs improve prime editing efficiencyJames W Nelson, Peyton B Randolph, Simon P Shen, et al.
Journal of Virology|May 14, 2004
Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitroMatthew B Elliott, Karin S Pryharski, Qingzhong Yu, et al.
The Journal of Infectious Diseases|March 5, 2005
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infantsRuth A Karron, Peter F Wright, Robert B Belshe, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 1998
Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutantR A Karron, D A Buonagurio, A F Georgiu, et al.
Vaccine|December 1, 1996
Identification of mutations contributing to the reduced virulence of a modified strain of respiratory syncytial virusK P Tolley, A C Marriott, A Simpson, et al.
Cell|January 12, 2022
Engineered virus-like particles for efficient in vivo delivery of therapeutic proteinsSamagya Banskota, Aditya Raguram, Susie Suh, et al.
Journal of Virology|July 29, 2004
Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) proteinMatthew B Elliott, Karin S Pryharski, Qingzhong Yu, et al.
Nature Biotechnology|May 4, 2023
Efficient prime editing in mouse brain, liver and heart with dual AAVsJessie R Davis, Samagya Banskota, Jonathan M Levy, et al.
Pageof 8